The aim of this study was to determine the association of the Pro141Leu polymorphism in the PLAU gene with PCa, and also to investigate the changes in serum expression levels of uPA and its receptor (uPAR) in PCa patients compared with controls. The gene discussed is PLAU; the disease is posterior cortical atrophy.